Press Release Pedia
Home » Health & Fitness » The clinical trials software market is projected to grow at an annualized rate of 14%, till 2035
Health & Fitness

The clinical trials software market is projected to grow at an annualized rate of 14%, till 2035

R A R A
May 24, 2022

Roots Analysis has announced the addition of “Clinical Trials Software Market, 2022-2035”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

 

To order this 270+ page report, which features 60+ figures and 50+ tables, please visit https://www.rootsanalysis.com/reports/clinical-trial-software-market.html

 

Key Market Insights

  • 70+ companies worldwide claim to have developed software solutions allowing decentralization of the clinical research process, optimizing time and cost spent on clinical trials
  • The current market landscape, with the presence of both established players and new entrants offering clinical trials software with advanced features, is highly fragmented
  • The domain has witnessed a considerable increase in partnerships and collaborations over the past few years, indicating the rising interest of stakeholders
  • Notably, 10 M&A instances were recorded in 2021, signaling a gradual shift towards consolidation; geographical expansion is amongst the key value driver behind this trend
  • Foreseeing lucrative returns, many public and private investors have made investments worth USD 550 million, marking a surge in funding activity
  • Clinical trial management system : Driven by the substantial progress in this domain, encouraging virtual clinical trial results, and ongoing technological advancement, the clinical trials software market is anticipated to grow at a commendable pace in the mid to long term.
  • We expect the market to grow at an annualized rate of 14% in the coming decade; the opportunity is likely to be well distributed across features of software and key geographical regions

 

Clinical trial management software

It is a well-known fact that clinical trials form an integral part of the overall drug development process, enabling innovators to assess safety and efficacy of their drug candidates / devices. These studies account for around 50% of the total time and capital invested in the development process

 

For more information, please visit https://www.rootsanalysis.com/reports/clinical-trial-software-market.html

 

Table of Contents

 

1          PREFACE

1.1.      Scope of the Report

1.2.      Key Questions Answered

1.3.      Research Methodology

1.4.      Chapter Outlines

 

  1. EXECUTIVE SUMMARY

 

  1. INTRODUCTION

3.1.      Chapter Overview

3.2.      Existing Constraints in Clinical Research

3.2.1.   Increasing Trial Costs and Complexity

3.2.2.   Evolving Regulatory Standards

3.2.3.   Patient Recruitment and Retention-Related Challenges

3.2.4.   Inefficient Data Handling

 

3.3.      Virtual Clinical Trials

3.3.1.   Electronic Data Capture Solutions

3.3.2.   Electronic Clinical Outcome Assessment and Electronic Patient Reported Outcome Solutions (eCOA / ePRO)

3.3.3.   Electronic Consent Solutions

 

3.4.      Opportunities and challenges associated with Virtual Clinical Trials Management

3.5      Future Perspectives

 

4          MARKET LANDSCAPE

4.1.      Chapter Overview

4.2.      Clinical Trials Software Market: List of Products

4.2.1.   Analysis by Type of Deployment

4.2.2.   Analysis by Type of Delivery

4.2.3.   Analysis by End-User

4.2.4.   Analysis by Features of Software

4.2.5.   Analysis by Trial Design

4.2.6.   Analysis by Type of Technology

4.3.      Clinical Trials Software Market: Developer Landscape

4.3.1.   Analysis by Year of Establishment

4.3.2.   Analysis by Company Size

4.3.3.   Analysis by Geography

 

  1. CLINICAL TRIALS SOFTWARE DEVELOPERS: COMPANY PROFILES

5.1.      Chapter Overview

5.2.      Advarra

5.2.1.   Company Overview

5.2.2.   Product Portfolio: Clinical Trials Software

5.2.3.   Recent Developments and Future Outlook

 

5.3.      Arisglobal

5.3.1.   Company Overview

5.3.2.   Product Portfolio: Clinical Trials Software

5.3.3.   Recent Developments and Future Outlook

 

5.4.      AssistRx

5.4.1.   Company Overview

5.4.2.   Product Portfolio: Clinical Trials Software

5.4.3.   Recent Developments and Future Outlook

 

5.5.      Chapter overview

5.5.1.   Calyx

5.5.2.   Company Overview

5.5.3.   Product Portfolio: Clinical Trials Software

5.5.4.   Recent Developments and Future Outlook

 

5.6.      Clario

5.6.1.   Company Overview

5.6.2.   Product Portfolio: Clinical Trials Software

5.6.3.   Recent Developments and Future Outlook

 

5.7.      IBM

5.7.1.   Company Overview

5.7.2.   Product Portfolio: Clinical Trials Software

5.7.3.   Recent Developments and Future Outlook

 

5.8.      IQVIA

5.8.1.   Company Overview

5.8.2.   Product Portfolio: Clinical Trials Software

5.8.3.   Recent Developments and Future Outlook

 

5.9.      Medidata

5.9.1.   Company Overview

5.9.2.   Product Portfolio: Clinical Trials Software

5.9.3.   Recent Developments and Future Outlook

5.10.    Oracle

5.10.1. Company Overview

5.10.2. Product Portfolio: Clinical Trials Software

5.10.3. Recent Developments and Future Outlook

 

5.11.    Signant Health

5.11.1. Company Overview

5.11.2. Product Portfolio: Clinical Trials Software

5.11.3. Recent Developments and Future Outlook

 

5.12.    Veeva

5.12.1. Company Overview

5.12.2. Product Portfolio: Clinical Trials Software

5.12.3. Recent Developments and Future Outlook

 

 

  1. COMPANY COMPETITIVENESS ANALYSIS

6.1.      Chapter Overview

6.2.      Key Parameters and Methodology

6.3.      Competitiveness Analysis: Companies providing clinical trials software developers

6.4.      Competitiveness Analysis: Companies providing clinical trials software in   North America

6.5.      Competitiveness Analysis: Companies providing clinical trials software in Europe

6.6.      Competitiveness Analysis: Companies providing clinical trials software in Asia Pacific

 

  1. PARTNERSHIPS AND COLLABORATIONS

7.1.      Chapter Overview

7.2.      Partnership Models

7.3.      Clinical Trials Software Market: Partnerships and Collaborations

7.3.1.   Analysis by Year of Partnership

7.3.2.   Analysis by Type of Partnership

7.3.3.   Analysis by Type and Year of Partnership

7.4.      Geographical Analysis

7.4.1.   Analysis by Intracontinental and Intercontinental Agreements

7.4.2.   Analysis by Local and International Agreements

7.5.      Most Active Players: Analysis by Number of Partnerships

 

  1. MERGERS AND ACQUISITIONS

8.1.      Chapter Overview

8.2.      Mergers and Acquisitions Models

8.3.      Clinical Trials Software Market: Mergers and Acquisitions

8.3.1.   Analysis by Type of Agreement

8.3.2.   Analysis by Year of Mergers and Acquisitions

8.4.      Analysis by Geographical Activity

8.4.1.   Region-wise Analysis

8.4.2.   Mergers and Acquisitions: Intercontinental and Intracontinental Deals

8.5.      Most Active Players: Analysis by Number of Instances Acquisitions and Mergers

 

  1. FUNDING AND INVESTMENT ANALYSIS

9.1.      Chapter Overview

9.2.      Types of Funding Instances

9.3.      Clinical Trials Software Market: Recent Funding Instances

9.3.1.   Analysis by Year of Investment

9.3.2.   Analysis by Amount Invested

9.3.3.   Analysis by Type of Funding

9.4.      Most Active Players: Analysis by Number of Funding Instances

9.5.      Regional Analysis by Amount Invested

9.6.      Concluding Remarks

 

10        MARKET SIZING AND OPPORTUNITY ANALYSIS

10.1.    Chapter Overview

10.2.    Forecast Methodology and Key Assumptions

10.3.    Global Clinical Trials Software Market, 2022-2035

10.3.1. Clinical Trials Software Market, 2022-2035: Distribution by Features of Software

10.3.1.1 Clinical Trials Software Market for Electronic Data Capture, 2022-2035

10.3.1.2 Clinical Trials Software Market for eCOA/ePRO, 2022-2035

10.3.1.3 Clinical Trials Software Market for eConsent, 2022-2035

10.3.2. Clinical Trials Software Market, 2021-2035: Distribution by Geographical Region

10.3.2.1. Clinical Trials Software Market in North America, 2022-2035

10.3.3.2. Clinical Trials Software Market in Europe, 2022-2035

10.3.4.3. Clinical Trials Software Market in Asia-Pacific, 2022-2035

 

 

  1. CONCLUDING REMARKS

 

  1. EXECUTIVE INSIGHTS

 

  1. APPENDIX 1: TABULATED DATA

 

  1. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

 

You may also be interested in the following titles:

  1. Novel Coronavirus (Covid-19): Preventive Vaccines, Therapeutics and Diagnostics in Development
  2. DNA-Encoded Libraries: Platforms and Services Market
  3. Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030

 

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

 

Contact:

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com

 

Facebook – https://www.facebook.com/RootsAnalysis

LinkedIn – https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter – https://twitter.com/RootsAnalysis

Medium – https://medium.com/@RootsAnalysis

Pinterest – https://in.pinterest.com/RootsanalysisPin/_saved/

Quora – https://rootsanalysisinsights.quora.com/

Tags:

Related Articles
Press Release Pedia
Logo
Shopping cart